Press Release - Verpora M&A Launch Announcement US

March 8th 2018

​Nick Merryfield LLP (NMLLP), a private equity firm focused on the healthcare industry, announced today the formation of a pioneering market access organization, the Verpora Group. Under an international agreement, the Verpora Group will help improve patient access to life-enhancing medicines through the integration of three specialized businesses.

In the first deal, NMLLP has taken a fifty-percent stake in White Space Analytics Ltd. (WSA), a data intelligence company with extensive experience in improving patient outcomes using predictive analytics and record-level data analysis. “We are delighted White Space Analytics will be helping spearhead the Verpora Group at a time of phenomenal growth for the organization,” said Nick Merryfield, Managing Partner of NMLLP and Chief Executive of the Verpora Group. “The business has a wealth of expertise in employing leading-edge data intelligence to help payers, providers, and manufacturers achieve improved patient access to life-enhancing technologies.”

Adam Meads, Founder of WSA, commented, “It is an exceptional opportunity to become a major part of the Verpora Group and help lead the company’s expansion. Data intelligence is now fundamental to ensuring the right patients, receive the right medicine, at the right time. I am extremely excited by the vision we offer our clients.”

In separate agreements, the healthcare investor announced that it will also bring Stisali Ltd. and WorldDataOnline LLC into the Verpora Group.

As experts in outcomes-based contracting, Stisali provides the inside track to optimizing the value that innovative technologies deliver. Conceived by former health system payers, Stisali specializes in the application of psychology and business consulting to develop customized value-based agreements and associated market access solutions for the U.S. market. “At a time of exceptional innovation for the pharmaceutical industry, demonstrating the true value medicines deliver is imperative. Verpora, through the amalgamation of payer insight and advanced data analytics, can now provide clients with trailblazing assistance. Ultimately, this will mean more patients will gain access to appropriate medicines”, said Omar Ali, Stisali founder and Head of Payers for the Verpora Group.

WorldDataOnline LLC is a Florida-based data management organization which processes highly-complex international healthcare information including real-world, patient-level and open data.

Andrew Wiles, Managing Partner, WorldDataOnline, said, “We are thrilled to be part of the Verpora Group. Effective management of large, healthcare data is fundamental to delivering high-quality insight to enable both manufacturers and payers understand where technologies best deliver value to patients.”

“Integrating Stisali, WSA, and, WorldDataOnline into the Verpora Group provides our clients with very powerful insight based on unparalleled data management and analysis. Our outputs will provide the next-generation of market access solutions to help more patients benefit from life-enhancing medicines,” said Meads.

The Verpora Group, which trades as Verpora, will work with health ecosystems to introduce new, and optimize existing, therapies through the following suite of solutions:

  • Strategic and expert payer advisory services
  • Outcomes-based, innovative contracting
  • Customized payer research and data analysis
  • Turnkey intelligence products
  • Real-world data management

For more information visit www.verpora.com.

With immediate effect, the group will trade as Verpora. The executives of each company will report to the Verpora Group, headed by Chief Executive, Nick Merryfield.  All businesses will be headquartered in the U.S. from Sarasota, Florida and across Europe from BioCity, Nottingham, U.K.

 

Financial details of the deal are not being disclosed.

 

For more information please view the accompanying press pack http://verpora.com/uploads/resources/Verpora-Press-Pack-US.pdf or contact:

General enquiries: nick.merryfield@verpora.com

Payer enquiries: omar.ali@verpora.com

Data enquiries: adam.meads@verpora.com

Telephone: +1 609-474-4811

About the author

Nick Merryfield

Nick Merryfield

Executive Chair of the Verpora Group and global healthcare innovator aiming to help improve patient access to life-changing medicines at a value sustainable to all stakeholders.